awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35607718-A062C55F-4246-4CBD-816F-3C45AD6985BC
Q35607718-A062C55F-4246-4CBD-816F-3C45AD6985BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35607718-A062C55F-4246-4CBD-816F-3C45AD6985BC
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
P2860
Q35607718-A062C55F-4246-4CBD-816F-3C45AD6985BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35607718-A062C55F-4246-4CBD-816F-3C45AD6985BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d5d16f65905ebb82974a3ecd651c4d1419a2485c
P2860
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model